BRPI1004637A2 - cosmetic products containing extracts and microalgal components and processes for their production - Google Patents
cosmetic products containing extracts and microalgal components and processes for their production Download PDFInfo
- Publication number
- BRPI1004637A2 BRPI1004637A2 BRPI1004637A BRPI1004637A2 BR PI1004637 A2 BRPI1004637 A2 BR PI1004637A2 BR PI1004637 A BRPI1004637 A BR PI1004637A BR PI1004637 A2 BRPI1004637 A2 BR PI1004637A2
- Authority
- BR
- Brazil
- Prior art keywords
- microalgal
- eps
- extracts
- biomass
- members
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 43
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 230000008569 process Effects 0.000 title claims abstract description 27
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 34
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 33
- 238000009472 formulation Methods 0.000 claims abstract description 22
- 230000001953 sensory effect Effects 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 11
- 239000003623 enhancer Substances 0.000 claims abstract description 3
- 239000006071 cream Substances 0.000 claims description 108
- 229920002444 Exopolysaccharide Polymers 0.000 claims description 77
- 239000002028 Biomass Substances 0.000 claims description 47
- 239000000047 product Substances 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 9
- 238000005119 centrifugation Methods 0.000 claims description 8
- 239000002798 polar solvent Substances 0.000 claims description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 4
- 239000006286 aqueous extract Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- 241000192660 Aphanizomenon Species 0.000 claims description 2
- 239000004166 Lanolin Substances 0.000 claims description 2
- 241000192500 Spirulina sp. Species 0.000 claims description 2
- 229940074979 cetyl palmitate Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000010908 decantation Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 229940008099 dimethicone Drugs 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 229940039717 lanolin Drugs 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical class CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims 2
- 238000000935 solvent evaporation Methods 0.000 claims 2
- 241000571821 Amphidinium sp. Species 0.000 claims 1
- 241000192542 Anabaena Species 0.000 claims 1
- 241000688154 Arthrodesmus Species 0.000 claims 1
- 241001495183 Arthrospira sp. Species 0.000 claims 1
- 241000180102 Botrydium Species 0.000 claims 1
- 241001536324 Botryococcus Species 0.000 claims 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 claims 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 1
- 241000192682 Calothrix sp. Species 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 241000195651 Chlorella sp. Species 0.000 claims 1
- 241000199485 Chromulina Species 0.000 claims 1
- 241000195501 Chroomonas sp. Species 0.000 claims 1
- 241001478772 Cladophoropsis Species 0.000 claims 1
- 241001465364 Cosmarium Species 0.000 claims 1
- 241000973888 Crinalium Species 0.000 claims 1
- 241000206585 Cyanidium Species 0.000 claims 1
- 241000206574 Cyanophora Species 0.000 claims 1
- 241000305506 Desmodesmus Species 0.000 claims 1
- 241001491745 Dixoniella Species 0.000 claims 1
- 241001560459 Dunaliella sp. Species 0.000 claims 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- 241000879485 Euastrum Species 0.000 claims 1
- 241000178983 Euglena sp. Species 0.000 claims 1
- 241001148149 Fremyella sp. Species 0.000 claims 1
- 241000206759 Haptophyceae Species 0.000 claims 1
- 241000206758 Heterosigma Species 0.000 claims 1
- 241000913084 Limnothrix Species 0.000 claims 1
- 241001134698 Lyngbya Species 0.000 claims 1
- 229910003206 NH4VO3 Inorganic materials 0.000 claims 1
- 241000509521 Nannochloropsis sp. Species 0.000 claims 1
- 241000059630 Nodularia <Cyanobacteria> Species 0.000 claims 1
- 241000192520 Oscillatoria sp. Species 0.000 claims 1
- 241000206766 Pavlova Species 0.000 claims 1
- 241000196152 Pediastrum Species 0.000 claims 1
- 241001305991 Phaeobotrys Species 0.000 claims 1
- 241000206619 Porphyra sp. Species 0.000 claims 1
- 241001302393 Porphyridium sp. Species 0.000 claims 1
- 241000894422 Pseudochlorella Species 0.000 claims 1
- 241000145442 Pseudomuriella Species 0.000 claims 1
- 241001414751 Rhodospora Species 0.000 claims 1
- 241000604181 Skeletonema sp. Species 0.000 claims 1
- 241000196301 Spirogyra sp. Species 0.000 claims 1
- 241000192560 Synechococcus sp. Species 0.000 claims 1
- 241000304537 Tetradesmus Species 0.000 claims 1
- 241000196321 Tetraselmis Species 0.000 claims 1
- 241000565373 Tetraspora sp. Species 0.000 claims 1
- 241000825484 Thalassiosira sp. Species 0.000 claims 1
- 229910008558 TiSO4 Inorganic materials 0.000 claims 1
- 241001633980 Xanthonema Species 0.000 claims 1
- 241000159633 Zygnema Species 0.000 claims 1
- 238000005273 aeration Methods 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000003125 aqueous solvent Substances 0.000 claims 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 1
- 239000001110 calcium chloride Substances 0.000 claims 1
- 235000011148 calcium chloride Nutrition 0.000 claims 1
- 229910001628 calcium chloride Inorganic materials 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 230000003750 conditioning effect Effects 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 238000000265 homogenisation Methods 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- 239000007791 liquid phase Substances 0.000 claims 1
- 229910000473 manganese(VI) oxide Inorganic materials 0.000 claims 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims 1
- 229960002216 methylparaben Drugs 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims 1
- 235000012162 pavlova Nutrition 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 238000000518 rheometry Methods 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000010344 sodium nitrate Nutrition 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 240000002900 Arthrospira platensis Species 0.000 abstract description 47
- 235000016425 Arthrospira platensis Nutrition 0.000 abstract description 42
- 229940082787 spirulina Drugs 0.000 abstract description 33
- 241000894007 species Species 0.000 abstract description 7
- 230000004071 biological effect Effects 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 5
- 244000005700 microbiome Species 0.000 abstract description 5
- 239000004519 grease Substances 0.000 abstract description 4
- 230000035807 sensation Effects 0.000 abstract description 4
- 230000003255 anti-acne Effects 0.000 abstract description 3
- 208000035484 Cellulite Diseases 0.000 abstract description 2
- 206010049752 Peau d'orange Diseases 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 230000036232 cellulite Effects 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 241001464430 Cyanobacterium Species 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 26
- 238000004458 analytical method Methods 0.000 description 21
- 229920001282 polysaccharide Polymers 0.000 description 20
- 239000005017 polysaccharide Substances 0.000 description 20
- 150000004804 polysaccharides Chemical class 0.000 description 19
- 230000006399 behavior Effects 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- 241001474374 Blennius Species 0.000 description 9
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 3
- -1 Polysaccharides Sulfates Chemical class 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000002956 ash Substances 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000037067 skin hydration Effects 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- SDNVJMZXSOXXQN-UHFFFAOYSA-N 3,4-ditert-butyl-2-methylphenol Chemical compound CC1=C(O)C=CC(C(C)(C)C)=C1C(C)(C)C SDNVJMZXSOXXQN-UHFFFAOYSA-N 0.000 description 2
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 2
- QXNWZXMBUKUYMD-ITUXNECMSA-N 4-keto-beta-carotene Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C QXNWZXMBUKUYMD-ITUXNECMSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 229920000189 Arabinogalactan Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 2
- 241000227647 Fucus vesiculosus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 244000042664 Matricaria chamomilla Species 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 241000206572 Rhodophyta Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 235000019312 arabinogalactan Nutrition 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- TXWRERCHRDBNLG-UHFFFAOYSA-N cubane Chemical compound C12C3C4C1C1C4C3C12 TXWRERCHRDBNLG-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ZRCXVNZZDQGBQT-XQIHNALSSA-N (3'R)-3'-hydroxy-echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)CCC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C ZRCXVNZZDQGBQT-XQIHNALSSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- MUCOHWBULSBLLZ-LSUAHRBSSA-N (3R,4S,5S,6R)-2-[(3S,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E)-2-hydroxy-25-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-2,6,10,14,19,23-hexamethylpentacosa-4,6,8,10,12,14,16,18,20,22,24-undecaen-3-yl]oxy-6-methyloxane-3,4,5-triol Chemical compound C[C@H]1OC(O[C@@H](\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)O)[C@H](O)[C@@H](O)[C@@H]1O MUCOHWBULSBLLZ-LSUAHRBSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- IMOYOUMVYICGCA-UHFFFAOYSA-N 2-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C=C1C(C)(C)C IMOYOUMVYICGCA-UHFFFAOYSA-N 0.000 description 1
- ZRCXVNZZDQGBQT-ZMSRUZMRSA-N 3'-Hydroxyechinenone Natural products O=C1C(C)=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@@H](O)CC=2C)\C)/C)\C)/C)C(C)(C)CC1 ZRCXVNZZDQGBQT-ZMSRUZMRSA-N 0.000 description 1
- ZRCXVNZZDQGBQT-BANQPSJHSA-N 3'-hydroxyechinenone Chemical compound CC=1C(=O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C ZRCXVNZZDQGBQT-BANQPSJHSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000195627 Chlamydomonadales Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241000195618 Cryptomonas Species 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000890204 Delesseria Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- HNYJHQMUSVNWPV-DRCJTWAYSA-N Diatoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1C#CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C HNYJHQMUSVNWPV-DRCJTWAYSA-N 0.000 description 1
- HNYJHQMUSVNWPV-QWJHPLASSA-N Diatoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C#CC1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C HNYJHQMUSVNWPV-QWJHPLASSA-N 0.000 description 1
- 241000195634 Dunaliella Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000195522 Fucales Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- MUCOHWBULSBLLZ-UHFFFAOYSA-N Myxoxanthophyll Natural products OC1C(O)C(O)C(C)OC1OC(C(C)(C)O)C=CC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(O)CC1(C)C MUCOHWBULSBLLZ-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000206755 Palmaria Species 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 241000192608 Phormidium Species 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 241000206618 Porphyridium Species 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000206616 Rhodymenia Species 0.000 description 1
- 241000195663 Scenedesmus Species 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001409064 Staurastrum orbiculare Species 0.000 description 1
- 235000021282 Sterculia Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241001491691 Thalassiosira Species 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 241000899931 Zygnemophyceae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000569 acute exposure Toxicity 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002001 anti-metastasis Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- 239000011774 beta-cryptoxanthin Substances 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006932 echinenone Nutrition 0.000 description 1
- YXPMCBGFLULSGQ-YHEDCBSUSA-N echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(=O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C YXPMCBGFLULSGQ-YHEDCBSUSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000001595 flow curve Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 231100000734 genotoxic potential Toxicity 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000399 hydroalcoholic extract Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000006609 metabolic stress Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 244000266996 perejil Species 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940059107 sterculia Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 239000000979 synthetic dye Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
PRODUTOS COSMéTICOS CONTENDO EXTRATOS E COMPONENTES MICROALGAIS E PROCESSO PARA PRODUçãO DOS MESMOS. A presente invenção trata do desenvolvimento de formulações cosméticas acrescidas de produtos e extratos microalgais. Várias espécies de micraolgas, dentre elas a cianobactéria Spirulina plotensis, vem sendo estudadas quanto às suas possíveis atividades biológicas nas áreas da saúde e alimentação. Porém, muitas das suas propriedades podem ser utilizadas para a produção de produtos cosméticos, como o seu poder antioxidante, de anti-envelhecimento, cicatrizante, anti-acne, redutor de oleosidade ou da celulite, entre outras. Além disso, vários dos seus produtos podem ser utilizados como melhoradores de características reológicas e sensoriais, proporcionando aos produtos maiores espalhabilidade, consistência, menores sensação graxa residual, brilho, velocidade de secagem, entre outras.COSMETIC PRODUCTS CONTAINING MICROALGAL EXTRACTS AND COMPONENTS AND PROCESS FOR THE PRODUCTION OF THE SAME. The present invention deals with the development of cosmetic formulations with added microalgal products and extracts. Several species of microorganisms, among them the cyanobacterium Spirulina plotensis, have been studied for their possible biological activities in the areas of health and nutrition. However, many of its properties can be used for the production of cosmetic products, such as its antioxidant, anti-aging, healing, anti-acne, oil-reducing or cellulite properties, among others. In addition, several of its products can be used as enhancers of rheological and sensory characteristics, providing products with greater spreadability, consistency, less residual grease sensation, shine, drying speed, among others.
Description
PRODUTOS COSMÉTICOS CONTENDO EXTRATOS E COMPONENTES MICROALGAIS E PROCESSO PARA PRODUÇÃO DOS MESMOSCOSMETIC PRODUCTS CONTAINING EXTRACTS AND MICROALGAL COMPONENTS AND PROCESS FOR THE SAME PRODUCTION
Campo da InvençãoField of the Invention
A presente invenção trata do desenvolvimento de formulações cosméticas acrescidas de componentes e extratos microalgais, com o intuito de trazer características melhoradas a tais produtos, como atividade biológica (poder antioxidante, anti-envelhecimento, cicatrizante, anti-acne, redutor de oleosidade, anti-celulite, entre outros) e propriedades reológicas e sensoriais melhoradas (maiores espalhabilidade, consistência, menor sensação graxa residual, brilho, velocidade de secagem, etc).The present invention is concerned with the development of cosmetic formulations with added microalgal components and extracts in order to bring improved characteristics to such products as biological activity (antioxidant power, anti-aging, healing, anti-acne, oil-reducing, anti-acne). cellulite, among others) and improved rheological and sensory properties (higher spreadability, consistency, less residual grease sensation, luster, drying rate, etc.).
Histórico da InvençãoInvention History
Formulações cosméticas são conhecidas e vem sendo desenvolvidas há séculos. Formulações base são fáceis de ser encontradas e manipuladas, e o grande diferencial são os aditivos usados em cada formulação, dando à mesma melhores características e propriedades. Por isso a extração de princípios ativos a partir de plantas, fruto, raízes, etc é amplamente estudada. A maioria das substâncias utilizadas para conservar os produtos cosméticos são substâncias sintéticas, como BHA (2 e 3-terc-butil- 4-hidroxianisol) e BHT (di-terc-butil metil fenol), que vem sendo estudados ao longo dos últimos anos, e demonstraram possível toxicidade quando há uma exposição a longo prazo. Além disso, como melhoradores reológicos atualmente são utilizados materiais minerais de fontes finitas, como caulim e talcos. Assim, a presente invenção objetiva o desenvolvimento de novos produtos cosméticos com moléculas bioativas de fonte microbiana, especificamente microalgais, capazes de conferir ao produto cosmético propriedades semelhantes ou melhores.Cosmetic formulations are known and have been developed for centuries. Base formulations are easy to find and manipulate, and the major differential is the additives used in each formulation, giving it the best characteristics and properties. Therefore the extraction of active ingredients from plants, fruit, roots, etc. is widely studied. Most of the substances used to preserve cosmetic products are synthetic substances such as BHA (2 and 3-tert-butyl-4-hydroxyanisol) and BHT (di-tert-butyl methyl phenol), which has been studied over the last few years. , and demonstrated possible toxicity when there is long term exposure. In addition, as rheological enhancers, finite source mineral materials such as kaolin and talc are currently used. Thus, the present invention aims at the development of novel cosmetic products with specifically microalgal bioactive source molecules capable of imparting similar or better properties to the cosmetic product.
Os cosméticos multifuncionais são os produtos que possuem funções além de sua função básica. Isto torna seu uso mais abrangente e melhora sua performance, sendo preferencialmente utilizados pelo consumidor. Nesse contexto, o produto apresentado nesta invenção apresenta além de propriedade hidratante, forte propriedade antioxidante. Os cremes com propriedades antioxidantes muitas vezes utilizam substâncias químicas como preservantes e antioxidantes (como BHA - 2 e 3-terc-butil-4-hidroxianisol e BHT - di-terc-butil metil fenol), cuja segurança vem sendo questionada.Multifunctional cosmetics are products that have functions beyond their basic function. This makes its use more comprehensive and improves its performance, being preferably used by the consumer. In this context, the product presented in this invention has in addition to moisturizing property, strong antioxidant property. Creams with antioxidant properties often use chemicals as preservatives and antioxidants (such as BHA - 2 and 3-tert-butyl-4-hydroxyanisol and BHT - di-tert-butyl methyl phenol), whose safety has been questioned.
O BHA é uma substância carcinogênica e irritante à pele, sendo que seu uso deve limitar-se aos valores sugeridos como seguros pelas legislações específicas.BHA is a carcinogenic and skin irritant, and its use should be limited to the values suggested as safe by specific laws.
O BHT apresenta baixa toxicidade aguda. Embora cause irritação à pele, conforme estudos realizados com porcos, o composto não parece causar irritação após ingestão nos níveis de uso permitidos em alimentos. Em estudos de exposição aguda realizados com camundongos, o BHT demonstrou efeitos tóxicos nos pulmões, incluindo hiperplasia, hipertrofia e uma desorganização geral dos constituintes celulares.BHT has low acute toxicity. Although it causes skin irritation, according to studies with pigs, the compound does not appear to cause irritation upon ingestion of permitted food use levels. In acute exposure studies in mice, BHT has shown toxic effects on the lungs, including hyperplasia, hypertrophy, and a general disruption of cellular constituents.
O TBHQ (t-butilhidroquinona) apresenta uma baixa toxicidade aguda e, embora em estudos realizados com porcos tenha apresentado uma discreta irritação á pele, não é considerado um composto irritante, devendo ser ingerido nos níveis permitidos em alimentos. Algumas evidências indicam que o TBHQ apresenta um baixo potencial genotóxico podendo ser discretamente mutagênico em altas doses.TBHQ (t-butylhydroquinone) has low acute toxicity and although in pig studies has shown slight skin irritation, it is not considered an irritant compound and should be ingested at the permitted levels in food. Some evidence indicates that TBHQ has a low genotoxic potential and may be slightly mutagenic at high doses.
O interesse pelos antioxidantes naturais teve início nos anos 80 diante da comprovação de efeitos maléficos causados por doses elevadas de BHT, BHA e TBHQ (t-butilhidroquinona) como sobrepeso do fígado e proliferação do retículo endoplasmático, entre outros. Conseqüentemente, ênfase foi dada à identificação e purificação de novos compostos com atividade antioxidante, provenientes de fontes naturais e que possam atuar sozinhos ou em sinergia com outros aditivos, como alternativa para prevenir a deterioração oxidativa de cosméticos e substituir o uso dos antioxidantes sintéticos.Interest in natural antioxidants began in the 1980s due to evidence of harmful effects caused by high doses of BHT, BHA and T-BQ (t-butylhydroquinone) as liver overweight and endoplasmic reticulum proliferation, among others. Consequently, emphasis has been placed on identifying and purifying new compounds with antioxidant activity from natural sources that may act alone or in synergy with other additives as an alternative to prevent oxidative deterioration of cosmetics and replace the use of synthetic antioxidants.
Estado da ArteState of art
Algas e microalgas e seus produtos são largamente utilizados no desenvolvimento de produtos cosméticos, como cremes, géis, xampus, etc. Polissacarídeos heterogênicos, chamados de mucilagens, são extraídos de algas marrons (Feoficeas) e vermelhas (Rodoficeas). Quando em contato com água, essa mucilagem forma um sistema coloidal, mas não adesivo, muito apreciado pela indústria cosmética. Dentre esses compostos, os mais utilizados são o alginato, o ágar e as carragenanas. Outras espécies, como Fucus vesiculosus (uma alga vermelha com propriedades emolientes) tem habilidade de acumular iodo, e são usadas em tratamentos anticelulíticos.Algae and microalgae and their products are widely used in the development of cosmetic products such as creams, gels, shampoos, etc. Heterogeneous polysaccharides, called mucilages, are extracted from brown (Feoficeas) and red (Rodoficeas) algae. When in contact with water, this mucilage forms a colloidal but non-adhesive system, much appreciated by the cosmetic industry. Among these compounds, the most used are alginate, agar and carrageenans. Other species, such as Fucus vesiculosus (a red algae with emollient properties) have the ability to accumulate iodine, and are used in anticellulitic treatments.
A biomassa de Macrohystis pyrifera em pó apresenta propriedades de regulação da secreção sebácea. Já a espécie Rhodymenia palmaria tem propriedades de combater a transpiração. Delesseria sangüínea e Undalaria punnatifada agem na pele tonificando-a, hidratando-a e tem ação anti-rugas. Dunaliella salina é uma fonte de pró- vitamina A (beta-caroteno), e os seus extratos estimulam a regeneração das células a nível de epiderme ou derme. Além disso, parece estimular a produção de melanina e tem poder antioxidante. A espécie Plocanium coccineum é uma fonte de pigmentos vermelhos, que podem substituir corantes sintéticos, diminuindo os riscos de toxicidade, por mais que apresentem estabilidade menor que os primeirosMacrohystis pyrifera biomass powder has sebaceous secretion regulating properties. Rhodymenia palmaria has sweating properties. Blood Delesseria and Punnatifada Undalaria act on the skin toning, moisturizing and anti-wrinkle action. Dunaliella saline is a source of pro-vitamin A (beta carotene), and its extracts stimulate cell regeneration at the epidermis or dermis level. In addition, it appears to stimulate melanin production and has antioxidant power. Plocanium coccineum is a source of red pigments that can replace synthetic dyes, reducing the risks of toxicity, even though they have less stability than the former.
Polissacarídeos microalgais são metabólitos importantes, representando de 40 a 90% dos compostos orgânicos produzidos por esses microrganismos. Eles tem um amplo espectro de composições e diferentes massas moleculares. No geral, polissacarídeos de microalgas podem ser divididos em três grupos maioritários: reserva, estrutural e extracelular.Microalgal polysaccharides are important metabolites, representing 40 to 90% of the organic compounds produced by these microorganisms. They have a wide spectrum of compositions and different molecular masses. In general, microalgae polysaccharides can be divided into three major groups: reserve, structural and extracellular.
Os principais polissacarídeos são os de reserva, geralmente compostos por glucanas homogêneas como amido e suas variações em cianobactérias e rodófitas.The main polysaccharides are the reserve polysaccharides, usually composed of homogeneous glucans such as starch and their variations in cyanobacteria and rhodophytes.
Polissacarídeos estruturais, presentes principalmente nas paredes celulares, podem variar enormemente em termos de composição, dependendo do grupo taxonômico, e incluem xilanas, mananas, ramnanas e várias glicoproteínas, sendo utilizados como um importante critério na definição de filos, classes e ordens de microalgas. Polissacarídeos extracelulares tem uma composição bastante variável, podendo formar compostos homogêneos contendo fucanas, mananas, arabinogalactanas, e heteropolissacarídeo contendo cinco ou mais tipos de monossacarídeos.Structural polysaccharides, present mainly in cell walls, can vary greatly in composition depending on the taxonomic group, and include xylans, mananas, rhamnanas, and various glycoproteins and are used as an important criterion in defining microalgae phyla, classes, and orders. Extracellular polysaccharides have a very variable composition and can form homogeneous compounds containing fucans, mananas, arabinogalactans, and heteropolysaccharides containing five or more types of monosaccharides.
Muitos dos polissacarídeos conhecidos tem sido estudados quanto à sua atividade biológica. A grande quantidade de frações com diferentes pesos moleculares e diferentes composições, produzidas por espécies de microalgas ainda não tão bem estudadas, mostra a possibilidade da descoberta de outros inúmeros compostos bioativos.Many of the known polysaccharides have been studied for their biological activity. The large number of fractions with different molecular weights and different compositions, produced by microalgae species not yet well studied, shows the possibility of the discovery of many other bioactive compounds.
Fucanas são polissacarídeos ricos em fucose, e apresentam um amploespectro de atividade biológica, incluindo efeito anticoagulante, anti-inflamatório, imunoestimulatório, anti-viral, anti-tumor e anti-metástase. As principais fontes são algas marrons (Classe Feofícea), particularmente das ordens Laminárias e Fucales, que produzem fucanas altamente sulfatadas conhecidas como fucoidan. Muitas espécies de microalgas podem também produzir fucanas com bioatividade, mas testes nessa área ainda são escassos. Crypfomonas obovata, Tetrapyrenoidosa cryptomonas (Cryptophyceae), Duostra thalassiosira (BaciIIariophyceae) and Staurastrum orbiculare (Zygnematophyceae) são exemplos de microalgas de água doce produtoras de polissacarídeos ricos em fucose.Fucanas are polysaccharides rich in fucose, and have a broad spectrum of biological activity, including anticoagulant, anti-inflammatory, immunostimulatory, anti-viral, anti-tumor and anti-metastasis effect. The main sources are brown algae (Feoficea Class), particularly from the Laminaria and Fucales orders, which produce highly sulphated fucanas known as fucoidan. Many microalgae species may also produce bioactivated fucans, but tests in this area are still scarce. Crypfomonas obovata, Tetrapyrenoidosa cryptomonas (Cryptophyceae), Duostra thalassiosira (BaciIIariophyceae) and Staurastrum orbiculare (Zygnematophyceae) are examples of freshwater microalgae producing polysaccharides rich in fucose.
Arabinanas, arabinogalactanas e ramnogalacturanas são muitas vezes associados com uma classe de compostos conhecidos como pectinas, caracterizadas pela presença de arabinos, galactose e ácido galacturônicos. Esses compostos são muito comuns em plantas superiores e plantas usadas em medicina tradicional. Muitas espécies de alga, especialmente aquelas filogeneticamente próximas às plantas superiores, apresentam pectinas na parede celular. Além disso, outras microalgas verdes exibem parede celular e polissacarídeos extracelulares similares à pectina, como glicoproteínas (feroporinas) que formam o envelope típico de Clamidomonadales Bars e Volvocales. A atividade imunoestimulatória de Chlorello sp. (ChlorococcaIes) é diretamente relacionada à presença de um polissacarídeo rico em arabinose e galactose.Arabinans, arabinogalactans and ramnogalacturans are often associated with a class of compounds known as pectins, characterized by the presence of arabins, galactose and galacturonic acid. These compounds are very common in higher plants and plants used in traditional medicine. Many algae species, especially those phylogenetically close to higher plants, have pectins in the cell wall. In addition, other green microalgae exhibit cell wall and pectin-like extracellular polysaccharides, such as glycoproteins (feroporins) that form the typical envelope of Clamidomonadales Bars and Volvocales. The immunostimulatory activity of Chlorello sp. (ChlorococcaIes) is directly related to the presence of a polysaccharide rich in arabinose and galactose.
Considerando os aspectos descritos, é evidente que a produção de polissacarídeos bioativos por microalgas deve ser melhor explorada. A bioprospecção mostra-se como uma ferramenta indispensável para a descoberta de novas substâncias de interesse humano.Considering the described aspects, it is evident that the production of bioactive polysaccharides by microalgae should be better explored. Bioprospecting is an indispensable tool for the discovery of new substances of human interest.
A produção de EPS (exopolissacarídeos) por microalgas freqüentemente ocorre em condições de cultivo relacionados a altos ou baixos pH e forte luminosidade. Uma grande produção de EPS ocasiona uma diminuição na eficiência da colheita da biomassa, dificultando a filtração e a centrifugação. Por outro lado, a presença de certa quantidade de EPS no meio parece facilitar a colheita, causando floculação.Microalgae production of EPS (exopolysaccharides) often occurs under high or low pH and high light conditions. A large production of EPS leads to a decrease in biomass harvesting efficiency, making filtration and centrifugation difficult. On the other hand, the presence of a certain amount of EPS in the medium seems to facilitate harvesting, causing flocculation.
Spirulina sp. secreta exopolissacarídeos sulfatados por meio da formação de cápsula e a gradiente liberação no meio de cultura. As aplicações promissoras de EPS de Spirulina estão relacionadas à sua atividade biológica e vem sendo investigadas, como atividade antitumoral, antioxidante, antibiótica, antiparasitária, etc.Spirulina sp. secretes sulfated exopolysaccharides through capsule formation and gradient release into the culture medium. The promising applications of Spirulina EPS are related to its biological activity and have been investigated as antitumor, antioxidant, antibiotic, antiparasitic activity, etc.
Não existem produtos nem estudos exatamente similares ao proposto nesta invenção. Alguns cremes utilizam extratos marinhos na sua composição, como os descritos a seguir.There are no products or studies exactly similar to those proposed in this invention. Some creams use marine extracts in their composition, as described below.
Um exemplo é o chamado "Advanced Marine Biology Cream", de La Prairie, que promete desacelerar o processo de envelhecimento através de ativos marinhos antioxidantes avançados, que parecem firmar a pele, através do ácido hialurônico, e por ter um "Complexo Protetor", que combate o envelhecimento com ceramidas de arroz, extrato de algas marinhas e algas verdes que ajudam a estimular a produção de colágeno. Segundo o fabricante, são utilizados Ativos Hidratantes (alga marinha, extratos de milho e outros agentes hidratantes) em sua composição. Promete proteger a pele, por meio de "ativos marinhos para proteção antioxidante com extratos de algas cultivadas com tecnologia mariponic e o perejil marinho que proporcionam à pele uma capacidade antioxidante de defesas sem precedentes". Informações complementares podem ser encontradas em http://www.laprairie.comAn example is La Prairie's "Advanced Marine Biology Cream", which promises to slow the aging process through advanced antioxidant marine actives that appear to firm the skin through hyaluronic acid, and to have a "Protective Complex", It fights aging with rice ceramides, seaweed extract and green algae that help stimulate collagen production. According to the manufacturer, moisturizing actives (seaweed, corn extracts and other moisturizing agents) are used in its composition. It promises to protect the skin through "marine actives for antioxidant protection with mariponic technology-grown seaweed extracts and marine perejil that give the skin an antioxidant capability of unprecedented defenses". Additional information can be found at http://www.laprairie.com
Outro exemplo é o creme "Creme Facial com Algas e Ervas", da Multi Vegetal, que diz ser um creme nutritivo para a pele da face com extratos de plantas ricas em nutrientes e antioxidantes naturais os quais atuam como supressores de radicais livres que causam a morte celular e o envelhecimento da pele. Segundo as referências, ele contém Algas Marinhas - Fucus vesiculosus (antioxidante e fonte de iodo natural), Babosa -Aloe sp. (nutritivo e suavizante) Camomila - Chamomilla recutita (calmante, tônica, refrescante e anti-inflamatória), Ginkgo -Ginkgo biloba (antiinflamatório, antioxidante e estimulante da circulação sangüínea) e Erva Mate -llex paraguariensis (poderoso hidratante e antioxidante natural). Disponível em: http://www.multivegetal.com/creme-facial-com-algas-e-ervas.phpAnother example is Multi Vegetal's "Seaweed and Herb Face Cream", which is said to be a nourishing cream for facial skin with nutrient-rich plant extracts and natural antioxidants that act as free radical suppressants that cause cell death and skin aging. According to the references, it contains Seaweed - Fucus vesiculosus (antioxidant and natural iodine source), Babosa -Aloe sp. (nourishing and soothing) Chamomile - Chamomilla recutita (soothing, tonic, refreshing and anti-inflammatory), Ginkgo-Ginkgo biloba (anti-inflammatory, antioxidant and blood circulation stimulant) and Herb Mate -llex paraguariensis (powerful moisturizer and natural antioxidant). Available at: http://www.multivegetal.com/creme-facial-com-algas-e-ervas.php
No entanto, nesse tipo de produto, os extratos utilizados são de macroalgas ("algas marinhas"), e não microalgas. Algas marinhas (macroalgas) têm o crescimento mais lento e delicado que as microalgas, que podem facilmente ser adaptadas a um processo produtivo industrial de grande escala.However, in this type of product, the extracts used are macroalgae ("seaweed"), not microalgae. Seaweed (macroalgae) has slower and more delicate growth than microalgae, which can easily be adapted to a large-scale industrial production process.
No trabalho "Diseno de una crema para masajes con extracto de spirulina cubana, de González et al, 2005, publicada na Revista Cubana de Farmacologia, do Instituto de Farmacia e Alimentos, da Universidad de La Habana", é relatada a preparação de uma formulação de creme com extrato hidroalcoólico de Spirulina, diferentemente do objeto desta invenção, em que se usa um extrato aquoso. Além disso, González et al 2005 não descrevem o uso do EPS produzido pela microalga. Além disso, o objetivo de uso do produto é diferente, pois o nosso trabalho foi desenvolver um creme hidratante para a pele, de uso contínuo, enquanto no trabalho de González et al, 2005, o objetivo é o uso em massagens, podendo inclusive ser removido após o uso, e não em uso contínuo.In the work "Disease of a cream for massage with extract of Cuban spirulina, by González et al, 2005, published in the Cuban Journal of Pharmacology, Institute of Pharmacy and Food, University of La Habana", the preparation of a formulation is reported. of cream with Spirulina hydroalcoholic extract, unlike the object of this invention, wherein an aqueous extract is used. Moreover, González et al 2005 do not describe the use of EPS produced by microalgae. In addition, the purpose of using the product is different, as our work was to develop a moisturizing skin cream for continuous use, while in the work of González et al, 2005, the goal is to use it in massages, and may even be removed after use, not in continuous use.
Algumas patentes já relatam a utilização de microalgas e seus compostos para a produção de produtos cosméticos. No entanto, nenhuma das patentes encontradas até o presente momento utiliza nem os mesmos microrganismos nem os mesmos processos para a obtenção de um produto com capacidade antioxidante e propriedades reológicas e sensoriais melhoradas, como apresentado na presente patente.Some patents already report the use of microalgae and their compounds for the production of cosmetic products. However, none of the patents found to date use neither the same microorganisms nor the same processes to obtain a product with antioxidant capacity and improved rheological and sensory properties as disclosed in the present patent.
A patente W02010054322A1 intitulada "Cosmetic Compositions Compising Microalgal Components" utiliza células microalgais inteiras com determinado teor de caroteóides, e contem pelo menos 10% de óleo, sendo livre de qualquer outro tipo de óleo. São cremes que devem ser aplicados por meio de compressas, que duram entre 1 e 3 horas, não sendo para uso tópico nem contínuo. Nesse trabalho, não é mencionada a utilização de EPS dos microrganismos testados para melhoria das características reológicas nem sensoriais.W02010054322A1 entitled "Cosmetic Compositions Compising Microalgal Components" utilizes whole microalgal cells with a certain carotid content, and contains at least 10% oil and is free of any other oil. These creams should be applied by compresses, which last between 1 and 3 hours, not for topical or continuous use. In this work, the use of EPS of the tested microorganisms to improve rheological or sensory characteristics is not mentioned.
Já na patente W003000222A2 "Cosmetic Preparation With Anti-wrinkle action" utiliza-se um extrato aquoso de biomassa microalgal do qual purifica-se um peptídeo, que parece combater o envelhecimento da pele.Already in patent W003000222A2 "Cosmetic Preparation With Anti-wrinkle action" is used an aqueous extract of microalgal biomass from which a peptide is purified, which appears to combat skin aging.
Na patente WO 2007/110511 "Cosmetic active ingredient composed of arginine ferrulate and a microalgae extract and its issues" o objetivo é a aumentar a atividade dos proteosomas da pele para que se aumente a produção de tioredoxina e reduzir a produção de proteínas glicolisadas. Isso é feito por meio da obtenção de um extrato hidroglicólico capaz de induzir tais reações. Ele é obido por meio de extrações de biomassas da microalgas Chlorella, Scenedesmus e Spirulina, e um extrato de café verde.In WO 2007/110511 "Cosmetic active ingredient composed of arginine ferrulate and microalgae extract and its issues" the objective is to increase the activity of skin proteosomes to increase thioredoxin production and to reduce the production of glycolyzed proteins. This is done by obtaining a hydroglycolic extract capable of inducing such reactions. It is obtained by extracting biomass from microalgae Chlorella, Scenedesmus and Spirulina, and a green coffee extract.
A patente FR276499A1 "Produit Cosmétique pour protéger épiderme des effets de la pollution atmosphérique" tem por objetivo a produção de um cosmético capaz de proteger a pele contra poluição, utilizando extratos de microrganismos marinhos do gênero Phormidium. Utiliza extratos até 0,1% em peso no produto final, e tem por base manter ou aumentar a quantidade de ATP intracelular nas células epidérmicas. A patente FR2785909A1 "Extract de micro-algae contenant de substances antiradicalaires et des polyssacharides sulfates et composition 1'incorporant" relata um processo para a obtenção de materiais de origem microalgal com atividade antioxidante. Essa atividade é devida à ação da enzima superóxido dismutase obtida por stress metabólico forçado. As espécies utilizadas são Porphyridium cruenfum e espécies pertencentes às Rodofícias.FR276499A1 "Cosmetic Product for the Protection of Epidermis of the Effects of Air Pollution" aims to produce a cosmetic product capable of protecting the skin against pollution using extracts of marine microorganisms of the genus Phormidium. It uses extracts up to 0.1% by weight in the final product, and is based on maintaining or increasing the amount of intracellular ATP in epidermal cells. FR2785909A1 "Microalgae Extract Containing Antiradical Substances and Polysaccharides Sulfates and Composition 1'incorporant" discloses a process for obtaining microalgal materials of antioxidant activity. This activity is due to the action of the enzyme superoxide dismutase obtained by forced metabolic stress. The species used are Porphyridium cruenfum and Rodophytic species.
A patente MD3781F1 "Procedeu de obtinere a preparatului antioxidant termostabil di biomassa cianobacteriei Spirulina platensis" relata processo produtivo que utiliza o meio de cultivo Gromov adicionado de ácido tartárico e imidazol. As células obtidas são rompidas por congelamento/descongelamento e o processo de recuperação dos princípios ativos inclui a utilização de superóxido dismutase.Patent MD3781F1 "Proceeded to obtain the preparation of antioxidant thermostable cyanobacterial biomass Spirulina platensis" discloses a production process using Gromov culture medium added with tartaric acid and imidazole. The obtained cells are disrupted by freezing / thawing and the recovery process of the active ingredients includes the use of superoxide dismutase.
A patente US7651690 "Purified component of blue-green algae and method of use" descreve a utilização de microalgas como Aphanizomenon e Spirulina para a produção de selectinas, descrevendo seu isolamento, purificação e uso.US7651690 "Purified component of blue-green algae and method of use" describes the use of microalgae such as Aphanizomenon and Spirulina for the production of selectins, describing their isolation, purification and use.
Descrição Resumida da InvençãoBrief Description of the Invention
A presente invenção trata do desenvolvimento de formulação cosmética contendo extrato aquoso de biomassa de microalga, que apresenta propriedades antioxidantes, e o polissacarídeo obtido da mesma microalga, para a melhoria de aspectos reológicos e sensoriais do produto cosmético.The present invention deals with the development of cosmetic formulation containing aqueous microalgae biomass extract, which has antioxidant properties, and the polysaccharide obtained from the same microalgae, for the improvement of rheological and sensory aspects of the cosmetic product.
Citação das Figuras (caso houver)Citation of Figures (if any)
A Figura I ilustra a curva de crescimento de 5. platensis, durante 15 dias. Parâmetros de crescimento foram calculados: Pmax = 1,44g.L"1; Pmax = 0,42g.L'1.d'1, e Mmax= 0,43 day1.Figure I illustrates the growth curve of 5. platensis over 15 days. Growth parameters were calculated: Pmax = 1.44g.L "1; Pmax = 0.42g.L'1.d'1, and Mmax = 0.43 day1.
A Figura 2 ilustra o teste de potencial antioxidante pela metodologia da quimioluminescência, que pode ser utilizado para o cálculo do IC50 do extrato aquoso de biomassa. A Figura 3 ilustra o teste de potencial antioxidante pela metodologia da quimioluminescência, que pode ser utilizado para o cálculo do IC50 do EPS de Spirulina.Figure 2 illustrates the antioxidant potential test by the chemiluminescence methodology, which can be used to calculate the IC50 of the aqueous biomass extract. Figure 3 illustrates the antioxidant potential test by the chemiluminescence methodology, which can be used to calculate the Spirulina EPS IC50.
A Figura 4 mostra curvas obtidas por análise reológica dos cremes. No coso, são curvos de fluxo, do creme base (a), do creme com 0,5% de EPS (b); do creme com 2,5% de EPS de Spirulina (c); e do creme com 5.0% de EPS de Spirulina (d). Esses comportamentos mostram que a adição de valores mais altos de EPS (2,5 e 5%) atuam negativamente na tixotropia do produto, aumentando muito ou diminuindo muito as áreas de histerese (que podem ser vistas na figura como as áreas entre as curvas ascendentes e descendentes). O comportamento mais adequado mostra-se compatível com o mostrado na Figura (b), mostrando que a concentração de 0,5% de EPS foi a que apresentou um melhor resultado.Figure 4 shows curves obtained by rheological analysis of the creams. At the top are flow curves of the base cream (a), the cream with 0.5% EPS (b); the 2.5% EPS cream of Spirulina (c); and cream with 5.0% EPS of Spirulina (d). These behaviors show that the addition of higher EPS values (2.5 and 5%) negatively affects the product thixotropy, greatly increasing or decreasing the hysteresis areas (which can be seen in the figure as the areas between the upward curves). and descendants). The most appropriate behavior is compatible with that shown in Figure (b), showing that the concentration of 0.5% EPS showed the best result.
A Figura 5 mostra curvas obtidas por análise reológica dos cremes. No coso, são curvos de varredura de tensão, do creme base (a), do creme com 0,5% de EPS (b); do creme com 2,5% de EPS de Spirulina (c); e do creme com 5.0% de EPS de Spirulina (d). Esses comportamentos mostram que a gdição de valores mais altos de EPS (2,5 e 5%) atuam negativamente no comportamento dos módulos G' e G" da formulação. Para os creme Base e com 0,5% de EPS de Spirulina, o comportamento foi praticamente constante, mostrado pelas curvas quase totalmente horizontais. Já para as outras duas formulações, contendo 2,5 e 5,0% de EPS esse comportamento não foi verificado, com distorções nos comportamentos das curvas. Assim, novamente, o comportamento mais adequado mostra-se compatível com o mostrado na Figura (b), mostrando que a concentração de 0,5% de EPS foi a que apresentou um melhor resultado.Figure 5 shows curves obtained by rheological analysis of the creams. At the top, they are strain sweeping curves of base cream (a), cream with 0.5% EPS (b); the 2.5% EPS cream of Spirulina (c); and cream with 5.0% EPS of Spirulina (d). These behaviors show that the determination of higher EPS values (2.5 and 5%) acts negatively on the behavior of the formulation's G 'and G "modules. For Spirulina Base cream and with 0.5% EPS, This behavior was practically constant, as shown by the almost completely horizontal curves, while for the other two formulations, containing 2.5 and 5.0% EPS, this behavior was not verified, with distortions in the behavior of the curves. Appropriate analysis is consistent with that shown in Figure (b), showing that the concentration of 0.5% EPS showed the best result.
A Figura 6 mostra curvas obtidas por análise reológica dos cremes. No coso, são curvas de vorredura de freqüência, do creme base (a), do creme com 0,5% de EPS (b); do creme com 2,5% de EPS de Spirulina (c); e do creme com 5.0% de EPS de Spirulina (d). Esses comportamentos mostram que a adição de valores mais altos de EPS (2,5 e 5%) atuam negativamente no comportamento dos módulos G' e G" da formulação. Para os creme Base e com 0,5% de EPS de Spirulina, o módulo G" foi praticamente constante e horizontal, e o móldulo G', apesar de apresentar comportamento levemente crescente (inclinado), apresentou-o de forma mais suave que os outros. Já para as outras duas formulações, contendo 2,5 e 5,0% de EPS esse comportamento não foi verificado, com distorções nos comportamentos das duas curvas. Assim, novamente, o comportamento mais adequado mostra-se compatível com o mostrado na Figura (b), mostrando que a concentração de 0,5% de EPS foi a que apresentou um melhor resultado.Figure 6 shows curves obtained by rheological analysis of the creams. At the top, they are frequency sweep curves, base cream (a), cream with 0.5% EPS (b); the 2.5% EPS cream of Spirulina (c); and cream with 5.0% EPS of Spirulina (d). These behaviors show that the addition of higher EPS values (2.5 and 5%) negatively affect the behavior of the formulation's G 'and G "modules. For Spirulina Base Cream and 0.5% EPS, module G "was practically constant and horizontal, and the module G ', despite presenting a slightly increasing (inclined) behavior, presented it more smoothly than the others. For the other two formulations, containing 2.5 and 5.0% EPS, this behavior was not verified, with distortions in the behaviors of the two curves. Thus, again, the most appropriate behavior is consistent with that shown in Figure (b), showing that the concentration of 0.5% EPS showed the best result.
A Figura 7 mostra curvas obtidas por análise reológica dos cremes. No caso, são curvas do teste chamado Creep and Recovery, do creme base (a), do creme com 0,5% de EPS (b); do creme com 2,5% de EPS de Spirulina (c); e do creme com 5.0% de EPS de Spirulina (d). O Creme Base e o creme com 0,5% de EPS mostraram praticamente a mesma recuperação, enquanto que para as outras duas formulações, as recuperações foram menores, indicando que esses dois cremes devem ser mais fluidos do que os dois primeiros, causando problemas na sua aplicação e uso, podendo escorrer pela pele, e podendo ter também uma aparência menos cremosa.Figure 7 shows curves obtained by rheological analysis of the creams. In this case, they are curves of the test called Creep and Recovery, the base cream (a), the cream with 0.5% EPS (b); the 2.5% EPS cream of Spirulina (c); and cream with 5.0% EPS of Spirulina (d). Base Cream and 0.5% EPS cream showed virtually the same recovery, while for the other two formulations, the recoveries were lower, indicating that these two creams should be more fluid than the first two, causing problems with its application and use, may run down the skin, and may also have a less creamy appearance.
A Figura 8 mostra curvas de atividade de água de cada creme em cada condição testada no teste de estabilidade acelerada. É possível notar que a atividade de água manteve-se praticamente constante após 90 dias de análise para todas as condições testadas para o Creme Spirulina (pontos demarcados com marcação verde) enquanto que os cremes base tiveram uma grande perda de atividade de água (pontos demarcados em vermelho), o que pode ser explicado pela capacidade de retenção de água pelo EPS.Figure 8 shows water activity curves of each cream under each condition tested in the accelerated stability test. It can be noted that the water activity remained practically constant after 90 days of analysis for all conditions tested for Spirulina Cream (green marked points) while the base creams had a large loss of water activity (marked points). in red), which can be explained by the water retention capacity of the EPS.
A Figura 9 mostra as médias de espalhabilidade encontradas para cada condição testada no teste de estabilidade acelerada. É possível notar que a temperaturas mais altas (Incubator) o creme perde água livre e resseca, o que interfere diretamente no valor da espalhabilidade do mesmo (tanto Creme Base quanto Creme Spirulina tiveram valores baixos de espalhabilidade nessa condição, quando comparado com as demais condições). É importante notar também que para todas as condições, o Creme Spirulina teve os melhores valor de espalhabilidade em relação à formulação Creme Base, mostrando que o EPS melhorou não apenas as características sensoriais mas também as características reológicas tornaram-se melhores.Figure 9 shows the averages of spreadability found for each condition tested in the accelerated stability test. It can be noted that at higher temperatures (Incubator) the cream loses free water and dryness, which directly interferes with its spreadability value (both Base Cream and Spirulina Cream had low values of spreadability in this condition, when compared to other conditions. ). It is also important to note that for all conditions Spirulina Cream had the best spreadability value compared to the Base Cream formulation, showing that EPS improved not only sensory characteristics but also rheological characteristics became better.
A Figura 10 mostra o resultado da avaliação sensorial realizada com os Cremes Base e Spirulina. As notas podiam variar entre 1 e 9. É possível notar que para o Creme Spirulina, objeto da presente invenção, todas as avaliações foram melhoresFigure 10 shows the result of the sensory evaluation performed with the Base Creams and Spirulina. The grades could range from 1 to 9. It can be noted that for the Spirulina Cream, object of the present invention, all ratings were better.
Descrição Detalhada da InvençãoDetailed Description of the Invention
O processo de obtenção do creme com propriedades antioxidantes e sensoriais diferenciadas inicia-se pelo cultivo da microalga. Dado o tempo de cultivo, a biomassa é recolhida por um processo de separação física, preferencialmente gravitacional, como filtração e centrifugação. Realiza-se a subseqüente secagem da biomassa a 60°C, mas podendo variar entre a temperatura ambiente e 100°C. Após a secagem a biomassa é triturada. A biomassa é diluída e homogeneizada em solvente polar (10 a 50% m/v), preferencialmente água. A mistura é centrifugada para a separação da biomassa e o extrato (sobrenadante) é utilizado.The process of obtaining cream with differentiated antioxidant and sensory properties begins with the cultivation of microalgae. Given the cultivation time, biomass is collected by a physical separation process, preferably gravitational, such as filtration and centrifugation. Subsequent drying of the biomass is performed at 60 ° C, but may vary between room temperature and 100 ° C. After drying the biomass is ground. The biomass is diluted and homogenized in polar solvent (10 to 50% w / v), preferably water. The mixture is centrifuged for biomass separation and the extract (supernatant) is used.
O sobrenadante, que é separado do cultivo da microalga, é concentrado (até 4 vezes do seu volume inicial) em rotaevaporador e precipitado com etanol (são utilizados até 4 volumes de etanol para cada volume de extrato concentrado). A mistura é deixada em freezer (-5 a -20°C) para melhor decantação do exopolissacarídeo (EPS). Após centrifugação, os sais remanescentes são removidos por meio de díálise preferencialmente com membrana de diálise de 16kDa (mas podendo variar entre 7 e 22kDa). O polissacarídeo purificado é então Iiofilizado para posterior aplicação. O creme-base utilizado trata-se de uma emulsão óleo/água contendo: Álcool ceto-estearílico etoxilado, Álcool ceto-estearílico, Fluido de Silicone (dimeticone copoliol), Palmitato de cetila, Miristato de isopropila, Propilparabeno, Metilparabenoi Propilenoglicol, Lanolina etoxilada 50%, e água destilada. A composição do creme-base não se restringe a este descrito; podem ser utilizados outros cremes-base aos quais serão adicionados o extrato de microaiga e seu EPS. Ao creme base são adicionados de 0,5 a 5% do polissacarídeo microalgal, e de 1 a 10 mL de uma extração aquosa a 5-40% da biomassa. As amostras são homogeneizadas e o pH ajustado entre 5 e 7 com solução ácida/básica.The supernatant, which is separated from the microalgae culture, is concentrated (up to 4 times its initial volume) in rotary evaporator and ethanol precipitated (up to 4 volumes of ethanol are used for each concentrated extract volume). The mixture is left in a freezer (-5 to -20 ° C) for better decantation of exopolysaccharide (EPS). After centrifugation, the remaining salts are removed by dialysis preferably with a 16kDa dialysis membrane (but may range from 7 to 22kDa). The purified polysaccharide is then lyophilized for later application. The base cream used is an oil / water emulsion containing: Ethoxylated Ketostearyl Alcohol, Ketostearyl Alcohol, Silicone Fluid (Dimethicone Copolyol), Cetyl Palmitate, Isopropyl Myristate, Propylparaben, Methylparabenoyl Propylene Glycol, Ethoxylated Lanolin 50%, and distilled water. The composition of the cream base is not restricted to that described; Other base creams may be used to which the microaiga extract and its EPS will be added. 0.5 to 5% of the microalgal polysaccharide is added to the base cream, and from 1 to 10 mL of a 5-40% aqueous extraction of the biomass. The samples are homogenized and the pH adjusted between 5 and 7 with acid / base solution.
Não há necessidade de se utilizar a célula inteira da microaiga, que não se dissolveria no creme, gerando problemas sensoriais e até mesmo de mau cheiro. Esses problemas são evitados pela formulação proposta nesta invenção, simultaneamente mantendo-se as propriedades antioxidantes da microaiga. Outra vantagem observada na formulação proposta é a eliminação da necessidade de se utilizar preservantes de origem química (moléculas sintéticas que são normalmente utilizadas para esse fim, e cuja segurança vem sendo questionada ultimamente, como o BHT e o BHA). Além disso, os polissacarídeos adicionados podem proporcionar ao creme propriedades sensoriais melhoradas e exclusivas que não seriam obtidas com a utilização de outras moléculas/ingredientes.There is no need to use the whole microaiga cell, which would not dissolve in the cream, creating sensory problems and even smelly. These problems are avoided by the formulation proposed in this invention while maintaining the antioxidant properties of the microaiga. Another advantage observed in the proposed formulation is the elimination of the need to use preservatives of chemical origin (synthetic molecules that are commonly used for this purpose, and whose safety has been questioned lately, such as BHT and BHA). In addition, the added polysaccharides may provide the cream with improved and unique sensory properties that would not be obtained with the use of other molecules / ingredients.
Os exemplos descritos a seguir mostram o uso de EPS e extrato de biomassa da microaiga Spirulino platensis. Porém, como citado anteriormente, as aplicações cosméticas do extrato aquoso e EPS de microalgas não se restringem a esta espécie.The following examples show the use of EPS and biomass extract from the Spirulino platensis microaiga. However, as previously mentioned, the cosmetic applications of microalgae aqueous extract and EPS are not restricted to this species.
Exemplo 1: Produção de Biomassa e Obtenção do EPS e Análise do PoderExample 1: Biomass Production and EPS Obtainment and Power Analysis
Antioxidante da Biomassa e do EPS A cepa de Spirulina platensis foi cultivada em Erlenmeyers de 6 litros (4L de volume útil) a 30°C em meio de cultivo Zarrouk. A iluminação foi fornecida por lâmpadas fluorescentes do tipo luz do dia fornecendo um total de 3500 lux. O período de luz utilizado foi igual a 12:12 h (luz / escuro). A agitação foi realizada com injeção de ar a 0,2-0,3 vvm. A concentração inicial de S. plafensis toi de 0,23g.L-1e o crescimento da biomassa foi monitorado por peso seco.Antioxidant of Biomass and EPS The Spirulina platensis strain was grown in 6 liter Erlenmeyers (4L useful volume) at 30 ° C in Zarrouk culture medium. Lighting was provided by daylight fluorescent lamps providing a total of 3500 lux. The light period used was 12:12 h (light / dark). Agitation was performed with air injection at 0.2-0.3 vvm. The initial concentration of S. plafensis toi of 0.23g.L-1 and biomass growth was monitored by dry weight.
As amostras foram retiradas diariamente e centrifugadas em centrífuga Mach Legend Sorvall 1,6 R (Sorvall, Alemanha) a 16800xg por 15 min. As células foram lavadas com água e secas a 60°C até peso constante, enquanto o meio livre de células foi utilizado para análise de açúcares totais pelo método fenol-sulfúrico (Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., Smith, E., 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-356.), estimando a produção de EPS.Samples were taken daily and centrifuged in a Mach Legend Sorvall 1.6 R centrifuge (Sorvall, Germany) at 16800xg for 15 min. The cells were washed with water and dried at 60 ° C to constant weight while the cell free medium was used for total sugar analysis by the phenol sulfuric method (Dubois, M., Gilles, KA, Hamilton, JK, Rebers, PA, Smith, E., 1956. Colorimetric method for determination of sugars and related substances (Anal. Chem. 28, 350-356.), Estimating EPS production.
A biomassa seca foi analisada quanto a clorofilas, carboidratos, proteínas, lipídeos e cinzas. Os pigmentos foram extraídos com acetona 90% e a quantificação seguiu as equações sugeridas por (Strickland, J.D.H., Parsons, T.R. A practical handbook of seawater analysis Pigment analysis. Buli. Fish. Res. Bd. Canada 167, 311. 1968). Lipídios foram determinados por extração com metanol: clorofórmio 1:1, seguido por uma extração líquido-líquido com hexano (Sydney, E.B., et al. Potential carbon dioxide fixation by industrially important microalgae. Bioresour. Technol. 20 2010). Cinzas foram quantificadas pelo método AOAC 941,12, enquanto método de fenol-sulfúrico foi utilizado para determinação de carboidratos totais e o método de Lowry (Lowry, O. H., N. J. Rosebrough, A.L. Farr and R. J. Randall1 1951. Protein measurement with the Folin-Phenol reagents. J. Biol. Chem. 193: 265-275) para determinação de proteína. Os compostos fenólicos 25 foram quantificados pelo método Folin-Ciocalteu (Costa, D.A., Chaves, M.H., Silva, W.C.S, Costi, C.H.S. Constituintes químicos, fenóis totais e atividade antioxidante de Sterculia striata St. Hil. et Naudin. Acta Amaz. vol.40 n°.1 Manaus, Mar. 2010), e o potencial antioxidante foi determinado através de duas metodologias distintas: o sistema de ensaio 2,2-difenil-1-picrilhidrazil 30 (DPPH) e testes de quimiluminescência, utilizando 10% (w/v) do extrato aquoso de biomassa. A cultura de S. platensis foi filtrada a vácuo em papel-filtro (Whatman 1). O filtrado foi concentrado até % do volume original de evaporador rotativo à vácuo abaixo de 50°C. O concentrado foi então dialisado em membrana de diálise de 12-14 KDa. Para a precipitação de EPS, quatro volumes de etanol absoluto foram adicionados ao concentrado obtido, sob agitação vigorosa. Essa mistura foi deixada overnight a 4°C. Após centrifugação a 16800xg por 10 min, o sobrenadante foi descartado. O EPS foi Iiofilizado e guardado para as aplicações subsequentes.Dry biomass was analyzed for chlorophylls, carbohydrates, proteins, lipids and ashes. The pigments were extracted with 90% acetone and quantification followed the equations suggested by (Strickland, J.D.H., Parsons, T. A practical handbook of seawater analysis Pigment analysis. Bull. Fish. Res. Bd. Canada 167, 311. 1968). Lipids were determined by extraction with 1: 1 methanol: chloroform followed by a liquid-liquid extraction with hexane (Sydney, E.B., et al. Potential carbon dioxide fixation by industrially important microalgae. Bioresour. Technol. 20 2010). Ash was quantified by the AOAC 941.12 method, while the phenol sulfuric method was used to determine total carbohydrates and the Lowry method (Lowry, OH, NJ Rosebrough, AL Farr and RJ Randall1 1951. Protein measurement with the Folin-Phenol J. Biol. Chem. 193: 265-275) for protein determination. Phenolic compounds 25 were quantified by the Folin-Ciocalteu method (Costa, DA, Chaves, MH, Silva, WCS, Costi, CHS. Chemical constituents, total phenols and antioxidant activity of Sterculia striata St. Hil et Naudin. Acta Amaz. Vol. 40 No. 1 Manaus, Mar. 2010), and the antioxidant potential was determined by two distinct methodologies: the 2,2-diphenyl-1-picrylhydraz 30 (DPPH) assay system and chemiluminescence testing using 10% ( w / v) of aqueous biomass extract. The S. platensis culture was vacuum filtered on filter paper (Whatman 1). The filtrate was concentrated to% of the original volume of vacuum rotary evaporator below 50 ° C. The concentrate was then dialyzed on a 12-14 KDa dialysis membrane. For the precipitation of EPS, four volumes of absolute ethanol were added to the obtained concentrate under vigorous stirring. This mixture was left overnight at 4 ° C. After centrifugation at 16800xg for 10 min, the supernatant was discarded. The EPS was lyophilized and saved for subsequent applications.
A concentração de polissacarídeo extracelular foi determinada de acordo com o método clássico de Dubois et al. (1956) utilizando solução de glicose como padrão de referência.Extracellular polysaccharide concentration was determined according to the classical method of Dubois et al. (1956) using glucose solution as a reference standard.
A análise da composição de EPS foi realizada em um aparelho de HPLC (High Performance Liquid Chromatrography) da marca Shimadzu equipado com um detector de índice de refração. A coluna utilizada foi Aminex HPX87H, com as condições de análise: H2SO4 5mm, 60°C, 0,6 mL / min.Analysis of the EPS composition was performed on a Shimadzu brand High Performance Liquid Chromatrography (HPLC) equipped with a refractive index detector. The column used was Aminex HPX87H, with the analysis conditions: 5mm H 2 SO 4, 60 ° C, 0.6 mL / min.
A curva de crescimento obtida para a cianobactéria S. platensis pode ser vista na figura 1.The growth curve obtained for S. platensis cyanobacteria can be seen in figure 1.
A composição geral da biomassa Spirulina platensis em termos de proteínas, açúcares, pigmentos, lipídios e cinzas é mostrada na tabela 1.The general composition of Spirulina platensis biomass in terms of proteins, sugars, pigments, lipids and ashes is shown in table 1.
Tabela 1: Composição centesimal de biomassa de S. platensis.Table 1: Centesimal composition of S. platensis biomass.
<table>table see original document page 15</column></row><table><table> table see original document page 15 </column> </row> <table>
Teste de compostos fenólicos foram realizados na biomassa e nos polissacarídeos, utilizando para tal uma dissolução inicial de 10% (v / w). Spirulina platensis contém muito tipos de pigmentos, incluindo clorofila-a, xantofila, beta-caroteno, echinenona, myxoxanthophyll, zeaxantina, cantaxantina, diatoxantina, 3'-hydroxyechinenona, beta-criptoxantina e oscillaxantina, além da ficobiliproteínas c-ficocianina e aloficocianina . Todos os pigmentos enumerados têm pelo menos uma região fenólica característica, que pode desempenhar um papel como antioxidante. O teor de compostos tenólicos totais foi igual a 150,39 mg por 100 g de biomassa. A quantidade de clorofilas a e b e os carotenóides são apresentados na Tabela 2.Phenolic compounds tests were performed on biomass and polysaccharides, using an initial dissolution of 10% (v / w). Spirulina platensis contains many types of pigments, including chlorophyll-a, xanthophyll, beta-carotene, echinenone, myxoxanthophyll, zeaxanthin, canthaxanthin, diatoxanthin, 3'-hydroxyechinenone, beta-cryptoxanthin, and cophanocyanocyanin and phycobilocyanine. All listed pigments have at least one characteristic phenolic region, which may play a role as an antioxidant. The content of total tenol compounds was 150.39 mg per 100 g of biomass. The amount of chlorophylls a and b and carotenoids are shown in Table 2.
Tabela 2: Quantificação de Clorofila e Carotenóides da biomassa de S. platensis.Table 2: Chlorophyll and carotenoids quantification of S. platensis biomass.
<table>table see original document page 16</column></row><table><table> table see original document page 16 </column> </row> <table>
O potencial antioxidante da biomassa de Spirulina platensis foi quantificado através do método de quimioluminescência. Gráficos de barras mostrado na figura 4 indicam o sinal medido pelo equipamento, proporcional ao teor de radicais livres. Assim, amostras com poder antioxidante superior possuem menores áreas de resposta por esse método.The antioxidant potential of Spirulina platensis biomass was quantified by chemiluminescence method. Bar graphs shown in figure 4 indicate the signal measured by the equipment, proportional to the free radical content. Thus, samples with superior antioxidant power have smaller response areas by this method.
O solvente utilizado nas diluições foi tampão fosfato, pH 7,4. Um controle foi feito com água destilada.The solvent used in the dilutions was phosphate buffer, pH 7.4. A control was made with distilled water.
Observa-se claramente pela Figura 2 que a amostra de biomassa teve uma capacidade de quase 100% de inibição de radicais livres a uma concentração de aproximadamente 2,0 mg / mL. Assim, o IC50 da amostra pode ser calculado, o que eqüivale a 0,962 mg / ml.It is clearly seen from Figure 2 that the biomass sample had an almost 100% free radical inhibiting ability at a concentration of approximately 2.0 mg / mL. Thus, the IC50 of the sample can be calculated, which equals 0.962 mg / ml.
Como comparativo, o BHT (di-terc-butil metil-fenol) possui um IC50 igual a 12,5 pg / mL e BHA (terc-butil-4-hidroxianisol) igual a 2,97 yg / mL.By comparison, BHT (di-tert-butyl methylphenol) has an IC 50 of 12.5 pg / mL and BHA (tert-butyl-4-hydroxyanisol) of 2.97 µg / mL.
A produção de EPS por Spirulina platensis foi acompanhada durante 14 dias, atingindo O^ógL-1, o que significa 0.183gEPS/gbiomass (18,3%). O saldo teórico para Spirulina platensis pode chegar a 51%, especialmente quando cultivada em condições de estresse (temperatura, iluminação e/ou pH, por exemplo). O EPS não-dialisado liofilizado apresentou uma aparência muito semelhante ao caulim. Ambos tem baixa densidade, aspecto claro e baixa densidade.The production of EPS by Spirulina platensis was followed for 14 days, reaching O ^Gl-1, which means 0.183gEPS / gbiomass (18.3%). The theoretical balance for Spirulina platensis can be up to 51%, especially when grown under stress conditions (temperature, lighting and / or pH, for example). Freeze-dried non-dialyzed EPS looked very similar to kaolin. Both have low density, light appearance and low density.
A composição monossacarídica dos EPS produzidos é mostradoa na tabela 3. Hexoses são os principais constituintes do EPS (manose, glicose e galactose), mas grande quantidade de pentoses também foi observada (ramnose e fucose).The monosaccharide composition of the EPS produced is shown in Table 3. Hexoses are the main constituents of EPS (mannose, glucose and galactose), but a large amount of pentose was also observed (rhamnose and fucose).
Tabela 3: Teor de proteína e carboidratos no EPS e sua composição monossacarídica.Table 3: Protein and carbohydrate content in EPS and their monosaccharide composition.
<table>table see original document page 17</column></row><table><table> table see original document page 17 </column> </row> <table>
A quantidade de compostos fenólicos na EPS foi igual a 7,44 mg (em 100 g de amostra EPS). Para quantificar o potencial antioxidante do EPS o método de quimioluminescência dependente de Iuminol foi utilizado (Figura 3). O IC50 do EPS foi igual a 2,878 mg / ml. Esse valor é três vezes maior 15 que o do extrato de biomassa, o que significa que o extrato de biomassa testado é três vezes mais eficiente contra os radicais livres do que o EPS em si.The amount of phenolic compounds in the EPS was 7.44 mg (in 100 g EPS sample). To quantify the antioxidant potential of EPS the Iuminol-dependent chemiluminescence method was used (Figure 3). The IC50 of EPS was 2.888 mg / ml. This value is three times greater than that of biomass extract, which means that the biomass extract tested is three times more efficient against free radicals than EPS itself.
Exemplo 2: Análise reolóaica de cremes acrescidos de diferentes concentrações de EPSExample 2: Rheological analysis of creams plus different EPS concentrations
Quatro conjuntos de cremes foram preparadas, utilizando a formulação já descrita. Para três desses cremes foi adicionado EPS de Spirulina em concentrações crescentes de 0,5%, 2,5% e 5,0%. Um controle foi utilizado sem adição de EPS. Os cremes foram mantidas em frascos opacos a 4°C. Quatro horas antes das análises, os cremes foram deixados em temperatura ambiente até entrar em equilíbrio térmico.Four sets of creams were prepared using the formulation already described. Spirulina EPS was added to three of these creams at increasing concentrations of 0.5%, 2.5% and 5.0%. One control was used without addition of EPS. The creams were kept in opaque jars at 4 ° C. Four hours prior to analysis, the creams were left at room temperature until thermal equilibrium.
A análise reológica foi realizada em um reômetro Mod Brooktield RV III, utilizando um sistema cone-placa, Software Rheocalc 3.0. e um spindle CP 52. A análise foi realizada em triplicata utilizando 0,4 g da amostra. Todos os cremes testados (com ou sem adição de Spirulina EPS) mostraram um comportamento não-newtoniano, pseudoplástico e viscoelástico e tixotrópico. A área de histerese mais adequada foi atingida com 0,5% de EPS de Spirulino platensis. Essa mesma composição apresentou a melhor viscosidade aparente, indicando melhor espalhabilidade em relação aos demais cremes.Rheological analysis was performed on a Mod Brooktield RV III rheometer using a cone-plate system, Rheocalc 3.0 Software. and a CP 52 spindle. The analysis was performed in triplicate using 0.4 g of the sample. All creams tested (with or without the addition of Spirulina EPS) showed non-Newtonian, pseudoplastic and viscoelastic and thixotropic behavior. The most appropriate hysteresis area was achieved with Spirulino platensis EPS 0.5%. This same composition presented the best apparent viscosity, indicating better spreadability in relation to the other creams.
As varreduras de freqüência e tensão foram realizadas para observar o comportamento dos módulos G 'e G de cada amostra. O creme base e o creme com 0,5% de EPS mostraram o padrão mais constante, o que indica melhor estabilidade da emulsão (distorcida em outros cremes, provavelmente pela grande quantidade de partículas sólidas). As figuras de 4 a 7 ilustram os testes realizados com os cremes com diferentes concentrações de EPS de Spirulina.Frequency and voltage scans were performed to observe the behavior of the G 'and G modules of each sample. Base cream and 0.5% EPS cream showed the most constant pattern, which indicates better emulsion stability (distorted in other creams, probably by the large amount of solid particles). Figures 4 to 7 illustrate the tests performed with creams with different concentrations of Spirulina EPS.
Exemplo 3: Análise de EstabilidadeExample 3: Stability Analysis
Foi preparado um quilo de creme de base, que foi dividido em duas partes, sendo que em uma delas foram adicionados 0,5% (p/p) de EPS de Spirulina platensis e 2ml de extrato aquoso de biomassa (10% v/w)a. Cada parte foi dividida em 5 frascos de plástico com capacidade para 120g, contendo cada um 90-100g de creme. Os frascos foram distribuídos para avaliar a resposta a diferentes condições. Um frasco de creme base e um de creme base contendo extrato de biomassa e EPS de S. platensis foram deixados sob as seguintes condições: temperatura ambiente, geladeira (5°C), estufa (37°C), agitador (120rpm, 27°C) e prateleira iluminada (3500lux, 27°C).One kilogram of base cream was prepared, which was divided into two parts, in which 0.5% (w / w) EPS of Spirulina platensis and 2ml of aqueous biomass extract (10% v / w) were added. )The. Each part was divided into 5 120g plastic jars each containing 90-100g of cream. The vials were distributed to assess response to different conditions. One jar of base cream and one base cream containing S. platensis biomass extract and EPS were left under the following conditions: room temperature, refrigerator (5 ° C), oven (37 ° C), shaker (120rpm, 27 ° C) and illuminated shelf (3500lux, 27 ° C).
A estabilidade dos cremes-teste foi avaliada durante 90 dias (de estabilidade acelerada). O creme de Spirulina apresentou melhor capacidade de retenção de água (Figura 8), indicando maior poder hidratante.The stability of the test creams was evaluated for 90 days (accelerated stability). Spirulina cream had better water retention capacity (Figure 8), indicating greater moisturizing power.
Ambos os cremes apresentaram variações negativas, quando incubadas a temperaturas elevadas, pois houve perda de água, sendo modificado o aspecto geral do creme e diminuindo a sua espalhabilidade (Figura 9). Para todas as outras condições, o creme de Spirulina apresentou melhores valores de espalhabilidade do que o creme base.Both creams showed negative variations when incubated at elevated temperatures, as there was water loss, changing the overall appearance of the cream and reducing its spreadability (Figure 9). For all other conditions, Spirulina cream had better spreadability values than base cream.
Exemplo 4: Análise Sensorial de creme contendo Extrato aauoso deExample 4: Sensory Analysis of Cream containing Aauous Extract of
biomassa e EPSbiomass and EPS
A análise sensorial foi realizada em um grupo de 35 adultos voluntários. Todas as pessoas foram informadas sobre o conteúdo da prova, bem como dos riscos a ela inerentes. Os testes foram realizados somente após a assinatura do termo de acordo e contrato de adesão.Sensory analysis was performed on a group of 35 volunteer adults. Everyone was informed about the content of the proof and the risks inherent in it. The tests were performed only after signing the agreement and adhesion agreement.
Os dois cremes avaliados possuíam a mesma composição básica. A diferença entre os chamados "Creme Base" do "Creme Spirulina" foi a adição de 0,5% de EPS da microalga Spirulina platensis e 4mL/kg de 10% de extrato aquoso de biomassa.Both creams evaluated had the same basic composition. The difference between the so-called "Base Cream" of the "Spirulina Cream" was the addition of 0.5% EPS of Spirulina platensis microalgae and 4mL / kg of 10% aqueous biomass extract.
Dois kits foram preparados, cada um contendo as amostras e materiais de apoio (espátulas, água, toalha e guardanapos de papel). As amostras foram numeradas aleatoriamente, de modo que o voluntário não possa estabelecer uma relação lógica entre eles.Two kits were prepared, each containing the samples and supporting materials (spatulas, water, towel and paper napkins). The samples were randomly numbered so that the volunteer could not establish a logical relationship between them.
Quatro medidas de hidratação inicial da pele foram feitas antes da aplicação dos cremes, utilizando o dispositivo Corneometer CM825. As regiões foram demarcadas no antebraço dos membros do painel, com pontos nos vértices de quadrados medindo 3,5 cm χ 3,5 centímetros (12,25 cm 2) para a aplicação. Um molde foi usado porque a medição da hidratação da pele deve ser feita exatamente nas regiões onde os cremes foram aplicados. Os integrantes do grupo foram, então, convidados a dar início à avaliação e ao responder ao questionário.Four initial skin hydration measurements were made prior to application of the creams using the Corneometer CM825 device. The regions were demarcated on the forearm of the panel members, with points at the square vertices measuring 3.5 cm χ 3.5 cm (12.25 cm 2) for application. A mold was used because the measurement of skin hydration must be done exactly in the regions where the creams were applied. The group members were then invited to start the evaluation and to answer the questionnaire.
Para a aplicação uma pequena porção dos cremes avaliados foi retirada do recipiente com uma espátula, evitando a contaminação através do contato dos dedos do membro do painel com o creme remanescente no frasco. Uma vez colocado sobre a pele, o creme foi espalhado manualmente, em 15-20 movimentos circulares, até completa absorção.For application a small portion of the evaluated creams was removed from the container with a spatula, avoiding contamination through the contact of the panel member fingers with the remaining cream in the jar. Once placed on the skin, the cream was spread by hand in 15-20 circular motions until completely absorbed.
O questionário foi feito com base em uma análise afetiva. Os seguintes parâmetros foram escolhidos: aspecto, consistência, velocidade de secagem, brilho, espalhabilidade, pegajosidade, sensação graxa residual e impressão global. Além disso, duas questões foram adicionadas a respeito da atitude de compra do creme. A primeira questão era sobre a atitude de compra com base nas características do creme avaliado, e a segunda sobre a influência da presença de um extrato antioxidante natural na formulação do creme.The questionnaire was based on an affective analysis. The following parameters were chosen: appearance, consistency, drying speed, brightness, spreadability, tackiness, residual grease sensation and overall impression. In addition, two questions were added regarding the cream's buying attitude. The first question was about the buying attitude based on the characteristics of the cream evaluated, and the second question about the influence of the presence of a natural antioxidant extract on the cream formulation.
O creme Spirulina teve uma melhor avaliação quanto a sua consistência, a velocidade de secagem, brilho, espalhabilidade viscosidade, e sensação graxa residual. A impressão geral também foi melhor para o Creme de Spirulina. O potencial de compra do creme Spirulina foi muito superior ao Creme Base. O resumo da avaliação de cada aspecto de cada creme pode ser visualizado na figura 10.Spirulina cream had a better rating for its consistency, drying speed, glossiness, viscosity spreadability, and residual grease sensation. The overall impression was also better for Spirulina Cream. The buying potential of Spirulina cream was much higher than Base Cream. The summary of the evaluation of each aspect of each cream can be seen in figure 10.
O poder hidratante do creme contendo Spirulina foi maior do que o creme base, mostrando que além de melhorar as propriedades sensoriais, a adição de EPS proporciona maior hidratação da pele.The moisturizing power of the Spirulina-containing cream was higher than the base cream, showing that in addition to improving sensory properties, the addition of EPS provides greater skin hydration.
Quando considerada a possível existência de um antioxidante natural nos cremes, a intenção de compra pelos os membros do painel aumentou.When considering the possible existence of a natural antioxidant in the creams, the buying intent by the panel members increased.
Exemplo 4: Análise de IrritabilidadeExample 4: Irritability Analysis
A metodologia escolhida para avaliar o potencial irritante cremes foi o Método de Draize, com modificações. Um grupo de 10 cobaias albinas (Cav/a porcellus), machos, com 120 dias de idade, foram utilizados. Antes de iniciar o experimento, eles" foram deixados em Biotério durante três semanas para aclimatação. Quando alcançaram 142 dias de idade, o teste foi realizado. Duas áreas do dorso dos animais foram raspadas, com o tamanho 8cmx5cm, 24 horas antes da aplicação de creme. Foi feita uma aplicação de 0,5 g de cada creme (um creme-base e um creme-base contendo extrato aquoso de biomassa a 10% e 0,5% de EPS) em cada área de todos os animais. Não foi necessário cobrir os locais de teste com gaze cirúrgica, tal como recomendado em algumas metodologias, pois o creme foi completamente e rapidamente absorvido pela pele dos animais. Os animais foram divididos em dois grupos de cinco: um grupo recebeu aplicação de creme base e o outro, o creme de Spirulina.The methodology chosen to evaluate potential irritating creams was the Draize Method, with modifications. A group of 10 male 120 day old albino guinea pigs (Cav / a porcellus) were used. Before starting the experiment, they were "left in the Vivarium for three weeks for acclimatization. When they reached 142 days of age, the test was performed. Two areas of the back of the animals were scraped, 8cmx5cm, 24 hours prior to application. 0.5 g of each cream (one base cream and one base cream containing 10% aqueous biomass extract and 0.5% EPS) was applied to each area of all animals. It is necessary to cover the test sites with surgical gauze as recommended in some methodologies as the cream was completely and rapidly absorbed into the animals' skin.The animals were divided into two groups of five: one group received base cream and the other , the cream of spirulina.
Os locais de aplicação foram visualmente observados logo após a aplicação e após 24 e 72h. Edema, eritema e escaras, assim como reversibilidade de possíveis reações após sete dias foram observadas.Application sites were visually observed immediately after application and after 24 and 72h. Edema, erythema and bedsores, as well as reversibility of possible reactions after seven days were observed.
Ambos EPS e creme base não causaram qualquer irritação na pele de cobaias. Assim sendo, o IIC (índice de irritabilidade cutânea) foi igual a zero.Both EPS and base cream did not cause any skin irritation on guinea pigs. Thus, the IIC (skin irritability index) was zero.
Claims (27)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1004637 BRPI1004637A2 (en) | 2010-11-12 | 2010-11-12 | cosmetic products containing extracts and microalgal components and processes for their production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1004637 BRPI1004637A2 (en) | 2010-11-12 | 2010-11-12 | cosmetic products containing extracts and microalgal components and processes for their production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1004637A2 true BRPI1004637A2 (en) | 2012-06-26 |
Family
ID=46330863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1004637 BRPI1004637A2 (en) | 2010-11-12 | 2010-11-12 | cosmetic products containing extracts and microalgal components and processes for their production |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI1004637A2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015084136A1 (en) * | 2013-12-06 | 2015-06-11 | Moroccan Foundation For Advanced Science, Innovation & Research (Mascir) | Use of a composition made from marine microalgae extracts for treating acne |
| FR3017051A1 (en) * | 2014-02-05 | 2015-08-07 | Biolog Marine Daniel Jouvance Lab De | COMPOSITION BASED ON SEAWATER AND ALGAE EXTRACTS AND USES THEREOF |
-
2010
- 2010-11-12 BR BRPI1004637 patent/BRPI1004637A2/en not_active Application Discontinuation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015084136A1 (en) * | 2013-12-06 | 2015-06-11 | Moroccan Foundation For Advanced Science, Innovation & Research (Mascir) | Use of a composition made from marine microalgae extracts for treating acne |
| FR3017051A1 (en) * | 2014-02-05 | 2015-08-07 | Biolog Marine Daniel Jouvance Lab De | COMPOSITION BASED ON SEAWATER AND ALGAE EXTRACTS AND USES THEREOF |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060233738A1 (en) | Composition for promoting production of type 1 collagen and/or elastin | |
| JPWO2004016236A1 (en) | Cosmetics | |
| JP4634769B2 (en) | Whitening effect improver, method for producing the same, whitening composition using the same, and external preparation for skin containing the same | |
| EP3436043B1 (en) | Compositions containing plant mucilage | |
| CN111228196A (en) | A kind of composition based on wheat germ extract, soothing baby face cream and preparation method thereof | |
| WO2014085876A1 (en) | Cosmetic composition | |
| Łęska et al. | Application of algae biomass and algae extracts in cosmetic formulations | |
| JP2015027998A (en) | Moisturizer, skin barrier function activator, tight junction formation accelerator, trpv4 expression enhancer, intracellular calcium concentration increaser, intracellular calcium concentration increaser, lipid synthesis accelerator, blood flow improver and periocular darkness ameliorator | |
| CN105997647A (en) | Anti-aging eye cream containing artemisia selengensis extract and preparation method thereof | |
| JP2001031552A (en) | Cosmetic composition containing moisture-retaining plant extract | |
| US7820211B2 (en) | Cosmetic material containing sweet pea extract | |
| JP2004010526A (en) | External preparation for skin | |
| JP2007131571A (en) | Hair papilla cell proliferation enhancer | |
| BRPI1004637A2 (en) | cosmetic products containing extracts and microalgal components and processes for their production | |
| CN106344458A (en) | Whitening cream containing ginseng and cornu cervi pantotrichum | |
| JP2012201670A (en) | Preparation for external use | |
| ES2614379T3 (en) | Association of miliacin and polar lipids, specifically sphingolipids and / or phospholipids, for hair and scalp care | |
| JP2004075635A (en) | Moisturizing agent and external preparation for skin | |
| WO2015083174A1 (en) | Preparations for suppressing or attenuating ocular irritancy | |
| JP2003342179A (en) | Anti-aging agent | |
| KR20160105584A (en) | COSMETIC COMPOSITIONS CONTAINING Rhododendron micranthum EXTRACT AND PREPARING METHOD OF THE SAME | |
| KR20150062625A (en) | Cosmetic Composition Comprising Ishige foliacea Extract, Gracilaria vermiculophylla (Ohmi)Papenfuss Extract, Dictyota coriacea, Pachydictyon coriaceum Extract and Sargassum horneri (Turner) C. Agardh Extract | |
| JP2004107242A (en) | Dry skin improvement kit | |
| JP5802930B2 (en) | Irritation relieving agent and hypoallergenic skin external preparation | |
| RU2481871C1 (en) | Hair and scalp cleansing shampoo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of an application: publication of a patent application or of a certificate of addition of invention | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B12C | Appeal: appeal against dismissal | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 8/99 , A61K 8/73 , C12N 1/12 , C12P 19/04 , A01G 33/00 , A61Q 19/06 , A61Q 19/08 , C12R 1/89 Ipc: A61K 8/99 (2006.01), A61K 8/73 (2006.01), A61Q 19/ |
|
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 8/99 (2006.01), A61K 8/73 (2006.01), A61Q 19/ |
|
| B09B | Decision: refusal |